Position for the Future
Build the AI healthcare core ecosystem through strategic M&A
Strategic Positioning
A world‑class capital platform driven by AI algorithms and high‑tech IP (K). M&A is our only lever to build an AI healthcare ecosystem. We do not build from zero—we identify, acquire, and integrate global category champions to deliver better, fairer healthcare for billions.
A Disruptive Operating Model: Finance – Acquire – Integrate – Profit Flywheel
Financing
Raise capital through dual listings and IP securitization via the capital operations platform.
Acquire
Use AI to screen global AI‑healthcare leaders and secure controlling stakes.
Integrate
Empower targets through the three curves + AI to unlock exponential growth.
Sustain Profit
Drive returns through synergy and capital operations, then reinvest to repeat the cycle.
Core Pain Points & ETHK Mission
Great missions start with great ideals. ETHK Labs aims to solve the healthcare impossible triangle: accessibility, quality, and cost. This is not only a commercial opportunity but a historic responsibility.
The Golden Decade of AI Healthcare
A once‑in‑a‑century window driven by tech, policy, capital, and demand.
M&A Opportunities
Policy tailwinds and capital momentum converge on high‑tech M&A.
State Council Policy (2024 Apr)
Encourages listed companies to focus on core business and use M&A to upgrade quality.
STAR Market Guidance (2024 Jun)
Supports industry‑chain M&A, relaxes constraints for pre‑profit tech targets.
M&A Six Measures (2024 Sep)
Position M&A as a core tool to build new productive forces and strategic sectors.
Regulator Pilot (2025)
M&A loan cap lifted to 80% and tenors extended to 10 years.
Major Asset Restructuring Update (2025 May)
Encourages PE participation and simplifies share‑purchase approvals.
Market Momentum
PwC’s 2025 China M&A review: H1 deal value up 45% YoY. Large deals >$1B hit 29, with high‑tech and healthcare leading—evidence of a positive policy‑capital loop.
State Council Policy (2024 Apr)
Encourages listed companies to focus on core business and use M&A to upgrade quality.
STAR Market Guidance (2024 Jun)
Supports industry‑chain M&A, relaxes constraints for pre‑profit tech targets.
M&A Six Measures (2024 Sep)
Position M&A as a core tool to build new productive forces and strategic sectors.
Regulator Pilot (2025)
M&A loan cap lifted to 80% and tenors extended to 10 years.
Major Asset Restructuring Update (2025 May)
Encourages PE participation and simplifies share‑purchase approvals.
Market Momentum
PwC’s 2025 China M&A review: H1 deal value up 45% YoY. Large deals >$1B hit 29, with high‑tech and healthcare leading—evidence of a positive policy‑capital loop.
Always Looking: Partnering with Visionaries
We continuously seek aligned partners worldwide. ETHK Labs offers more than capital—it provides a full enablement toolkit of channels, ecosystem, technology, and capital operations to help category leaders break growth ceilings and achieve exponential value creation.